Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

MediXall (MDXL) Receivables - Other (2020 - 2022)

MediXall's Receivables - Other history spans 3 years, with the latest figure at -$808810.0 for Q3 2022.

  • For Q3 2022, Receivables - Other fell 217.32% year-over-year to -$808810.0; the TTM value through Sep 2022 reached -$808810.0, down 217.32%, while the annual FY2021 figure was -$291159.0, 10614.95% down from the prior year.
  • Receivables - Other reached -$808810.0 in Q3 2022 per MDXL's latest filing, down from $657237.0 in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $657237.0 in Q2 2022 to a low of -$808810.0 in Q3 2022.
  • Average Receivables - Other over 3 years is -$125741.0, with a median of -$12231.0 recorded in 2021.
  • The largest YoY upside for Receivables - Other was 5473.53% in 2022 against a maximum downside of 17174.36% in 2022.
  • A 3-year view of Receivables - Other shows it stood at $2769.0 in 2020, then tumbled by 10614.95% to -$291159.0 in 2021, then crashed by 177.79% to -$808810.0 in 2022.
  • Per Business Quant, the three most recent readings for MDXL's Receivables - Other are -$808810.0 (Q3 2022), $657237.0 (Q2 2022), and -$472789.0 (Q1 2022).